
Bevacizumab Intravitreal Injection in Korea
Treatment Overview The Bevacizumab Intravitreal Injection Program in Korea is a specialized retinal treatment that uses Bevacizumab (AvastinĀ®), an anti-VEGF (vascular endothelial growth factor) medication,

